To include your compound in the COVID-19 Resource Center, submit it here.

MBI 853NL: Began Phase Ib trial

Micrologix Biotech Inc. (TSE:MBI; MGIXF), Vancouver, B.C.
Product: MBI

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE